tiprankstipranks
Trending News
More News >
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market

Enliven Therapeutics (ELVN) Balance Sheet

Compare
306 Followers

Enliven Therapeutics Balance Sheet

Enliven Therapeutics's total assets for Q3 2025 were $490.88M, a decrease of -2.58% from the previous quarter. ELVN total liabilities were $14.75M for the fiscal quarter, a -4.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 325.76M$ 271.87M$ 83.30M$ 113.33M$ 90.84M
Total Liabilities
$ 15.91M$ 25.96M$ 160.12M$ 6.47M$ 6.41M
Total Equity Gross Minority
$ 309.85M$ 245.91M$ -76.83M$ 106.86M$ 84.44M
Other Metrics
Currency in USD

Enliven Therapeutics Debt to Assets